世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

デジタル治療薬市場規模・シェア・動向分析レポート:アプリケーション別(糖尿病、肥満、CVD)、エンドユーザー別(患者、プロバイダー、支払者、雇用者)、地域別、セグメント予測、2022年~2030年


Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CVD), By End User (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2022 - 2030

デジタルセラピューティック市場の成長と動向 Grand View Research, Inc.の最新レポートによると、デジタル治療薬の世界市場規模は、2030年までに325億米ドルに達する見込みです。この市場は、2022年から2030... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年2月10日 US$5,950
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
150 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

デジタルセラピューティック市場の成長と動向

Grand View Research, Inc.の最新レポートによると、デジタル治療薬の世界市場規模は、2030年までに325億米ドルに達する見込みです。この市場は、2022年から2030年にかけて、26.1%の有利なCAGRで成長すると予想されています。市場成長の主な要因としては、COVID-19のパンデミックによる需要の高まり、様々な支援的な規制イニシアチブと償還の初期兆候、先進国および発展途上国におけるスマートフォンの普及率の上昇、慢性疾患の有病率の上昇などが挙げられます。さらに、医療機関や患者にとってデジタルヘルス技術は費用対効果が高く、統合医療システムや患者中心のケアに対する需要が高まっていることも、市場の成長を後押しすると考えられます。

COVID-19パンデミックは、デジタル治療ソリューションの導入を促進しました。Teladoc社の報告によると、遠隔医療の利用はパンデミック前の約38倍に増加しています。これらのソリューションの導入は、FDAなどの主要規制機関による支援策によっても支えられました。例えば、米国のFDAは2020年4月に、精神科患者に対するデジタルヘルス治療機器の利用を拡大するためのガイドラインを発表しました。Kepios社の調査によると、世界のインターネットユーザー数は年率7.6%で増加しており、毎日平均90万人のユーザーが新たに加わっていることになります。先進国や一部の発展途上国では、スマートフォンやインターネットの普及率が高い一方で、アフリカや南アジアなどの地域では、経済が発展していないために遅れています。

アフリカのスマートフォン市場は、ユーザー数が少ないながらも、手頃な価格の携帯電話が登場したことで、今後の成長が期待されています。これらの携帯電話は、1台あたりの価格が100米ドル以下で、人気を集めています。医療費の増加に伴い、費用対効果の高いヘルスケアへのニーズが高まっています。慢性疾患の発生率の上昇により、医療費が増加しています。このことは、発展途上国や先進国の経済成長に影響を与えています。より安価で代替的な医療提供手段を促進するために、追加コストを回避するためのデジタルヘルス技術が奨励されています。mHealthアプリケーションの使いやすさとその安定した性能は、個人やコミュニティの健康状態の改善に役立ち、市場の成長にプラスの影響を与えると予想されます。

デジタルセラピューティクス市場レポートのハイライト

- 2021年には、糖尿病の有病率の高さから、糖尿病アプリケーションセグメントが市場を支配しました

- 患者によるデジタル治療ソリューションの導入が進んでいることから、2021年には患者向けエンドユーザーセグメントが最大の収益シェアを占めました

- 2021年には、デジタルヘルス製品の使用が増加し、追跡・診断機能の向上による生活の質の向上に焦点を当てた有利な償還シナリオにより、北米が地域別市場の中心となりました。

- アジア太平洋地域は、パーソナル・ケア・デバイスと関連サービスの需要が高まっていることから、予測期間中に最も速いCAGRを記録すると予想されています。

ページTOPに戻る


目次

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Demand Sizing: Disease Prevalence Based Model
1.6.3 Region Based Segment Share Calculation
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million)
2.2 Digital Therapeutics Market Summary, 2021
Chapter 3 Digital Therapeutics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Digital Therapeutics Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 COVID-19 pandemic
3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.4 increasing smartphone penetration in developed and developing countries
3.3.1.5 cost-effectiveness of digital health technology for providers and patients
3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restraint analysis
3.3.2.1 low smartphone penetration in underdeveloped countries
3.3.2.2 COncerns over data protection
3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power: Low
3.4.2 Buyer Power: high
3.4.3 Threat Of Substitutes: Low
3.4.4 Threat Of New Entrants: High
3.4.5 Competitive Rivalry: High
3.5 Pestel Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social & Technological Landscape
3.6 Opportunity Analysis
Chapter 4 Digital Therapeutics Market: Competitive Analysis
4.1 Market Participation Categorization
4.1.1 Market Leaders & Innovators
4.1.1.1 company market position analysis
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 List Of Private Companies
Chapter 5 Digital Therapeutics Market: Covid-19 Impact
5.1 Disease Prevalence Analysis
5.2 Current And Future Impact Analysis
5.2.1 Current Impact Analysis
5.2.2 Future Impact Analysis
5.3 Impact On Market Players
Chapter 6 Digital Therapeutics Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Diabetes
6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
6.4 OBESITY
6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 CVD
6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Respiratory Diseases
6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Smoking Cessation
6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million)
6.8 CNS DISEASES
6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.9 OTHERS
6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Digital Therapeutics Market: End-Use Estimates & Trend Analysis
7.1 End-Use Market Share Analysis, 2021 & 2030
7.2 End-Use Dashboard
7.3 Patients
7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 Providers
7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Payers
7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million)
7.6 Employers
7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million)
7.7 Other End Users
7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 Digital Therapeutics Market: Regional Estimates & Trend Analysis, by Application, End-Use
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million)
8.3.3 Germany
8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6 Middle East And Africa (MEA)
8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 OMADA HEALTH, INC.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 WELLDOC, INC.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 2Morrow, Inc
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 STRATEGIC INITIATIVES
9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.)
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 PROPELLER HEALTH
9.5.1 Company Overview
9.5.2 Financial PERFORMANCE
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Fitbit, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 STRATEGIC INITIATIVES
9.7 CANARY HEALTH
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 MANGO HEALTH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 STRATEGIC INITIATIVES
9.9 NOOM, INC.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 STRATEGIC INITIATIVES
9.10 PEAR THERAPEUTICS
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 STRATEGIC INITIATIVES

 

ページTOPに戻る


 

Summary

Digital Therapeutics Market Growth & Trends

The global digital therapeutics market size is anticipated to reach USD 32.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 26.1% from 2022 to 2030. Key factors driving the market growth include high demand due to the COVID-19 pandemic, various supportive regulatory initiatives & early signs of reimbursements, increasing smartphone penetration in developed & developing countries, and the growing prevalence of chronic disorders. Moreover, the cost-effectiveness of digital health technology for providers & patients and increasing demand for integrated healthcare systems & patient-centric care are estimated to boost the market growth.

The COVID-19 pandemic catalyzed the adoption of digital therapeutics solutions. Teladoc reported that telehealth usage grew by about 38 times since pre-pandemic. The adoption of these solutions was further supported by supportive initiatives by key regulatory bodies, such as the FDA. For instance, the U.S. FDA released guidelines in April 2020 to expand the availability of digital health therapeutic devices for psychiatric patients. As per Kepios, globally, the number of internet users is growing at an annual rate of 7.6%, i.e., an average addition of 900,000 new users every day. While developed and certain developing economies have high smartphone and internet penetration, countries in regions, such as Africa and South Asia, are lagging due to their less advanced economies.

With a modest user base, Africa’s smartphone market is expected to grow due to the advent of affordable handsets in the country. These handsets are priced under USD 100 per unit and are gaining popularity. The need for cost-effective healthcare is increasing due to the growing healthcare expenditure. The rising incidence of chronic diseases has led to an increase in healthcare costs. This has affected economic growth in developing and developed economies. To promote cheaper and alternative means of healthcare delivery, digital health technologies are being encouraged to help avoid added costs. The ease of usage of mHealth apps and their consistent performance can help improve health outcomes of individuals and communities, which is anticipated to have a positive impact on market growth.

Digital Therapeutics Market Report Highlights

• The diabetes application segment dominated the market in 2021 due to the high prevalence of diabetes

• The patients' end-user segment held the maximum revenue share in 2021 owing to the high adoption of digital therapeutic solutions by patients

• In 2021, North America was the dominant regional market owing to the increased use of digital health products and favorable reimbursement scenarios that focus on improving quality of life through improved tracking & diagnostics

• Asia Pacific region is expected to register the fastest CAGR over the forecast period owing to the growing demand for personal care devices and related services



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Demand Sizing: Disease Prevalence Based Model
1.6.3 Region Based Segment Share Calculation
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million)
2.2 Digital Therapeutics Market Summary, 2021
Chapter 3 Digital Therapeutics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Digital Therapeutics Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 COVID-19 pandemic
3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.4 increasing smartphone penetration in developed and developing countries
3.3.1.5 cost-effectiveness of digital health technology for providers and patients
3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restraint analysis
3.3.2.1 low smartphone penetration in underdeveloped countries
3.3.2.2 COncerns over data protection
3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power: Low
3.4.2 Buyer Power: high
3.4.3 Threat Of Substitutes: Low
3.4.4 Threat Of New Entrants: High
3.4.5 Competitive Rivalry: High
3.5 Pestel Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social & Technological Landscape
3.6 Opportunity Analysis
Chapter 4 Digital Therapeutics Market: Competitive Analysis
4.1 Market Participation Categorization
4.1.1 Market Leaders & Innovators
4.1.1.1 company market position analysis
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 List Of Private Companies
Chapter 5 Digital Therapeutics Market: Covid-19 Impact
5.1 Disease Prevalence Analysis
5.2 Current And Future Impact Analysis
5.2.1 Current Impact Analysis
5.2.2 Future Impact Analysis
5.3 Impact On Market Players
Chapter 6 Digital Therapeutics Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Diabetes
6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
6.4 OBESITY
6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 CVD
6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Respiratory Diseases
6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Smoking Cessation
6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million)
6.8 CNS DISEASES
6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.9 OTHERS
6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Digital Therapeutics Market: End-Use Estimates & Trend Analysis
7.1 End-Use Market Share Analysis, 2021 & 2030
7.2 End-Use Dashboard
7.3 Patients
7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 Providers
7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Payers
7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million)
7.6 Employers
7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million)
7.7 Other End Users
7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 Digital Therapeutics Market: Regional Estimates & Trend Analysis, by Application, End-Use
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million)
8.3.3 Germany
8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6 Middle East And Africa (MEA)
8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 OMADA HEALTH, INC.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 WELLDOC, INC.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 2Morrow, Inc
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 STRATEGIC INITIATIVES
9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.)
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 PROPELLER HEALTH
9.5.1 Company Overview
9.5.2 Financial PERFORMANCE
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Fitbit, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 STRATEGIC INITIATIVES
9.7 CANARY HEALTH
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 MANGO HEALTH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 STRATEGIC INITIATIVES
9.9 NOOM, INC.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 STRATEGIC INITIATIVES
9.10 PEAR THERAPEUTICS
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 STRATEGIC INITIATIVES

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(diabetes)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/12 10:26

154.83 円

165.45 円

201.96 円

ページTOPに戻る